Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730042 | SCV000857750 | uncertain significance | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000730042 | SCV001778554 | likely benign | not provided | 2019-10-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003908036 | SCV004722035 | uncertain significance | EP300-related disorder | 2023-12-29 | criteria provided, single submitter | clinical testing | The EP300 c.1453C>A variant is predicted to result in the amino acid substitution p.Gln485Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |